The Enterprise Value as of June 2026 (TTM) for Newron Pharmaceuticals S.p.A. (NWPHF) is 298.35M

According to Newron Pharmaceuticals S.p.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 298.35M. This represents a change of 4.97% compared to the average of 284.21M of the last 4 quarters.

Newron Pharmaceuticals S.p.A. (NWPHF) Historical Enterprise Value (quarterly & annually)

How has NWPHF Enterprise Value performed in the past?

The mean historical Enterprise Value of Newron Pharmaceuticals S.p.A. over the last ten years is 157.07M. The current 298.35M Enterprise Value has changed 18.89% with respect to the historical average. Over the past ten years (40 quarters), NWPHF's Enterprise Value was at its highest in in the December 2025 quarter at 537.26M. The Enterprise Value was at its lowest in in the June 2006 quarter at 0.

Newron Pharmaceuticals S.p.A. (NWPHF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Newron Pharmaceuticals S.p.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Newron Pharmaceuticals S.p.A. (NWPHF) Average Enterprise Value

How has NWPHF Enterprise Value performed in the past?

The current Enterprise Value of Newron Pharmaceuticals S.p.A. (NWPHF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Newron Pharmaceuticals S.p.A. (NWPHF) Enterprise Value vs. Peers

How is NWPHF’s Enterprise Value compared to its peers?

Newron Pharmaceuticals S.p.A.’s Enterprise Value is greater than Faron Pharmaceuticals Oy (71.81M), less than AnGes, Inc. (17.66B), greater than Hamilton Thorne Ltd. (265.51M), less than Opsens Inc. (325.99M), greater than Recce Pharmaceuticals Ltd (155.49M), greater than Adocia S.A. (75.41M), greater than Dialogue Health Technologies Inc. (284.85M), greater than NIOX Group Plc (225.20M), greater than Planet 13 Holdings Inc. (90.15M), less than Guerbet S.A. (448.11M),

Build a custom stock screener for Newron Pharmaceuticals S.p.A. (NWPHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Newron Pharmaceuticals S.p.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Newron Pharmaceuticals S.p.A. (NWPHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Newron Pharmaceuticals S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.